InsidersTradesSigma
Track the 퓨쳐켐 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 퓨쳐켐 has recorded 41 public disclosures. Market capitalisation: €178.7bn. The latest transaction was filed on 22 June 2026 (Other). Among the most active insiders: 길희섭. The full history is openly available.
41
Insider Decl.
n/a
Thresholds
n/a
5 ops.
Buy Volume
n/a
26 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,127 of 29,064 companies
18.0
score / 100
Value20
Quality16
FCF yld-5.7%
Earn yld-5.9%
EV/EBITDA·
ROE-19%
Gross mgn23%
Net mgn-60%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 22 June 2026
Declarations41 total
25 of 41 declarations
About 퓨쳐켐
퓨쳐켐 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in developing innovative solutions for medical diagnosis and treatment.